Is N-acetylation of 5-aminosalicylic acid reversible in man?
Open Access
- 1 October 1984
- journal article
- Published by Wiley
- Vol. 18 (4) , 612-615
- https://doi.org/10.1111/j.1365-2125.1984.tb02513.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Disposition of 5-aminosalicylic acid, the active metabolite of sulphasalazine, in manEuropean Journal of Clinical Pharmacology, 1983
- Analysis of N4-trideuteroacetylsulphamerazine and its metabolites sulphamerazine and N4-acetylsulphamerazine in man by means of high-performance liquid chromatography and mass spectrometryJournal of Mass Spectrometry, 1983
- Rate limiting steps in metabolite kinetics: formation of 5-acetylaminosalicylate after administration of 5-aminosalicylateJournal of Pharmacy and Pharmacology, 1982
- TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMASThe Lancet, 1981
- Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's DiseaseNew England Journal of Medicine, 1980
- Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.Gut, 1980
- Capacity-limited Gut Wall Metabolism of 5-aminosalicylic acid, a Therapeutically Active Metabolite of Sulfasalazine, in RatsJournal of Pharmaceutical Sciences, 1979
- AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINEThe Lancet, 1977
- Clinical Pharmacokinetics of SulphasalazineClinical Pharmacokinetics, 1976
- Deacetylation of acetyl sulphapyridine in manJournal of Pharmacy and Pharmacology, 1973